Key words: antimicrobial treatment; diagnosis; Gram stain; outcome; pneumonia; sputum

Size: px
Start display at page:

Download "Key words: antimicrobial treatment; diagnosis; Gram stain; outcome; pneumonia; sputum"

Transcription

1 Applying Sputum as a Diagnostic Tool in Pneumonia* Limited Yield, Minimal Impact on Treatment Decisions Santiago Ewig, MD; Matthias Schlochtermeier, MD; Norbert Göke, MD; Michael S. Niederman, MD, FCCP Study objectives: We evaluated the role of sputum examination in the management of patients with community-acquired pneumonia (CAP) in a primary-care hospital without microbiologic laboratory facilities. Design and interventions: A diagnostic strategy using regular collection of sputum samples, Gram staining in a local laboratory, and mailing of samples to a commercial laboratory for culture analysis. Setting: A 200-bed primary-care hospital without subspeciality physicians. Patients: One hundred sixteen consecutive patients with a diagnosis of CAP were prospectively evaluated during a 12-month period. Results: Of 116 patients, 42 patients (36%) were capable of producing a sputum sample. Age > 75 years (odds ratio [OR], 0.4; 95% confidence interval [CI], 0.18 to 0.93) and prior ambulatory antimicrobial treatment (OR, 3.2; 95% CI, 1.2 to 8.4) were independent predictors of sputum production. A delay in collection and processing of sputum samples of > 24 h was present in 31% and 39%, respectively. A delay in collection yielded an increased number of Gram-negative enteric bacilli and nonfermenters (44% vs 7%, p 0.056). A delay in processing was associated with an increased number of Candida spp isolates (33% vs 9%, p 0.16). The overall diagnostic yield was low (10 of 116 patients, 9%) due to a limited number of valid samples (n 23 of 42 patients, 55%) and a limited number of definitely or probably positive samples on Gram s stain and culture (n 10 of 42 patients, 24%). Prior ambulatory antimicrobial treatment was associated with a reduction in diagnostic yield (14% vs 56%, p 0.09). The impact of diagnostic results on antimicrobial treatment decisions was minimal, with antimicrobial treatment directed to diagnostic results in only one patient. Conclusions: We conclude that in this setting representative of primary-care hospitals in Germany, sputum had a low diagnostic yield and did not contribute significantly to patient management. (CHEST 2002; 121: ) Key words: antimicrobial treatment; diagnosis; Gram stain; outcome; pneumonia; sputum Abbreviations: CAP community-acquired pneumonia; CI confidence interval; ERS European Respiratory Society; GNEB Gram-negative enteric bacilli; OR odds ratio *From the Medizinische Universitätsklinik und Poliklinik Bonn (Dr. Ewig), Bonn, Germany; Dreifaltigkeits-Krankenhaus Wesseling (Drs. Schlochtermeier and Göke), Wesseling, Germany; and Winthrop University Hospital (Dr. Niederman), Mineola, NY. Manuscript received February 22, 2001; revision accepted November 1, Correspondence to: Santiago Ewig, MD, Medizinische Universitätsklinik und Poliklinik Bonn, Innere Medizin/Kardiologie und Pneumologie, Sigmund-Freud-Strasse 25, Bonn, Germany; santiago.ewig@ukb.uni-bonn.de Current guidelines for the management of adult patients with community-acquired pneumonia (CAP) generally agree in recommending an initial empiric antimicrobial treatment based on both general and local microbiology and susceptibility patterns. 1 7 However, the role of sputum as a rapid diagnostic tool that could direct antimicrobial treatment is a matter of controversy. While some authorities 1,5,8 11 have outlined important limitations of this tool in terms of sensitivity, reliability, and impact on treatment decisions, others 3,4,12 15 have insisted on placing sputum at the top of any management algorithm. The recent update of the American Thoracic Society guidelines 5 recommends obtaining sputum samples only if a drug-resistant pathogen or an organism not covered by usual empiric treatment is suspected Clinical Investigations

2 Any standardized approach to patients with CAP must be adapted to local needs and limitations. Since the vast majority of patients with CAP in Germany are treated in primary-care hospitals, this is an important setting to validate any diagnostic approach. The value of collecting sputum samples is limited by the absence of a microbiology laboratory in most German primary-care hospitals. Therefore, in order to evaluate the role of sputum in the management of patients with CAP in this setting, we implemented a program of regular collection of sputum samples and Gram staining at the local, on-site laboratory as a diagnostic strategy. At the same time, we relied on the European Respiratory Society (ERS) guidelines adapted to current German susceptibility data for the selection of empiric antimicrobial treatment in the absence of a conclusive diagnostic result. 6 Study Hypothesis Materials and Methods The study was part of a follow-up interventional evaluation of the management of patients with CAP at the Dreifaltigkeits- Krankenhaus in Wesseling, a primary-care hospital with about 200 beds. 16 One part of the intervention consisted of evaluation of sputum samples as a diagnostic tool. The study hypothesis was that the sampling of sputum in this setting would result in a low diagnostic yield with a minimal impact on antimicrobial treatment decisions. The other part of the study included the implementation of the ERS guidelines for the selection of initial empiric antimicrobial treatment. 6 Setting The main characteristics of this hospital are the absence of any subspecialists within the Department of Internal Medicine, and the absence of a microbiology laboratory, resulting in the practice of mailing all diagnostic samples to a commercial laboratory for analysis. Patients Between June 1999 and May 2000, a total of 116 consecutive patients with a diagnosis of CAP were prospectively evaluated. The diagnosis of CAP was based on finding a new infiltrate on chest radiography, symptoms suggestive of a lower respiratory tract infection, and no alternative diagnosis made during followup. All patients were nonimmunosuppressed, and had not been hospitalized during the preceding month. Exclusion criteria were as follows: (1) the presence of severe immunosuppression (HIV infection, neutropenia /L, and organ transplantation); (2) patients referred from another hospital after initiation of antimicrobial treatment; (3) patients with witnessed gross aspiration; and (4) patients with pulmonary tuberculosis. The severity of pneumonia was classified according to the pneumonia severity index of Fine et al. 17 All patients were intended to be treated according to the ERS guidelines with modifications made in accordance with current German susceptibility patterns. Interventions An attempt to collect a sputum sample was made in all patients as soon as possible. The procedure of expectoration was explained in detail by the attending nurse, and the sputum sample was collected in a sterile tube. The nurse also documented the reasons for a failure to produce sputum. Immediately after obtaining the sample, it was processed in the local hospital laboratory. The macroscopic appearance was graded as mucoid or purulent. Then it underwent Gram staining and read at low ( 100) magnification by the local hospital laboratory technicians. Thereafter, samples meeting microscopic validity criteria were mailed to a commercial laboratory for culture. Otherwise, samples were discarded. The regular mailing time was 24 h. Antimicrobial treatment was never delayed in order to obtain a sample from any patient. Definitons A sample was judged macroscopically valid when the appearance was purulent. Following the criteria of Lentino and Lucks, 9 stained specimens were then scored 0, 1, or 2 according to the number of leukocytes, and 0, 1, and 2 according to the number of squamous epithelial cells seen per low power field. Specimen with scores of 1 were considered microscopically valid. 9 Gram stain was graded positive in the presence of a predominant organism, negative in the absence of any microorganism, and mixed flora in the absence of a predominant microorganism. A sputum sample was considered as definitely diagnostic for a cultured bacterial isolate when the following criteria were met: (1) the sample was macroscopically purulent and microscopically valid, (2) the Gram stain result was positive, (3) the same microorganism grew in culture as was seen on Gram stain, and (4) there were moderate-to-high amounts of growth according to semiquantitative evaluation criteria used by the laboratory. The sample was considered probably diagnostic in the presence of mixed flora on Gram stain, while meeting all other criteria. Candida spp were not considered an etiologic pathogen. Delay in collection or processing of sputum was referred to as a delay in obtaining or processing a sample for 24 h. Nonresponse to antimicrobial treatment was defined as persistent temperature 38 C and/or persistent clinical symptoms (malaise, cough, expectoration, or dyspnea) or clinical deterioration (development of acute respiratory failure requiring ventilatory support and/or septic shock) after 72 h of in-hospital antimicrobial treatment. Measurements The following end points were recorded: the number of patients capable of producing sputum, reasons for failure to produce sputum, macroscopic and microscopic validity of sputum samples and the association of both criteria, and the number of definite and probably diagnostic samples. In addition, the influence of the presence of COPD, prior ambulatory antimicrobial treatment, and delays in sampling and laboratory processing of samples on diagnostic results was analyzed. Finally, the impact of diagnostic results on antimicrobial treatment decisions was investigated, ie, the rate of using a targeted antimicrobial treatment according to diagnostic results, instead of using an empiric regimen. This assessment was done retrospectively, correlating treatment decisions to diagnostic results. Statistics Results are expressed as mean SD. Continuous variables were compared by Student s t test, and categorical variables were CHEST / 121 / 5/ MAY,

3 compared by 2 test or by Fisher Exact Test where appropriate. Predictors of productive cough were evaluated by a multivariate stepwise forward logistic regression analysis. The level of significance was set at p Results General Patient Characteristics and Outcome The patient population included 72 men and 44 women (62% and 34%, respectively). Mean age was years (range, 24 to 96 years), including 82 elderly patients (71%; age 65 years) of whom 50 patients (43%) were very elderly (age 75 years). Twenty-four patients (21%) were admitted to the hospital from nursing homes. At least one comorbidity (cardiac, pulmonary, hepatic, renal, CNS, diabetes mellitus, or neoplastic as previously defined 18 ) was present in 103 patients (89%). Using the classification according to the pneumonia severity score, there were 13 patients (11%) in risk class I, 7 patients in risk class II (6%), 11 patients in risk class III (10%), 48 patients in risk class IV (41%), and 37 patients in risk class V (32%). Initial antimicrobial treatment corresponded to the ERS guidelines in 85 cases (83%) and was inadequate treatment (according to guideline standards) in 17 cases (17%). Fourteen patients were not rated for adequacy of therapy because of decisions to limit treatment. Twenty-seven patients received monotherapy (aminopenicillin/ -lactamase-inhibitor [n 10], second-generation cephalosporin [n 5], macrolide [n 5], and levofloxacin [n 7]), and 89 patients received combination treatment (aminopenicillin/ -lactamase-inhibitor plus macrolide [n 71], aminopenicillin/ -lactamase-inhibitor plus levofloxacin [n 1], second-generation cephalosporin plus macrolide [n 9], and third-generation cephalosporin plus macrolide [n 8]). Twenty-two patients (19%) did not respond to initial antimicrobial treatment. Twenty patients (17%) were admitted at the ICU. Mortality rate was 15% (17 patients; 5 patients [10%] from risk class IV and 12 patients [32%] from risk class V). Sampling of Sputum Overall, 42 of 116 patients (36%) produced a sputum sample. Of these, 13 samples (31%) were not collected at hospital admission but 1 day after (n 10), 2 days after (n 2), and 3 days after (n 1). Reasons for failure to produce a sputum sample included unproductive cough efforts (n 31, 27%), weakness (n 23, 20%), and noncompliance (n 20, 17%). Age 75 years (odds ratio [OR], 0.45; 95% confidence interval [CI], 0.2 to 0.99; p 0.046), admission to the hospital from a nursing home (OR, 0.39; 95% CI, 0.13 to 1.1; p 0.078), prior ambulatory antimicrobial treatment (OR, 2.9; 95% CI, 1.1 to 7.3; p 0.024), and pulmonary comorbidity (OR, 2.0; 95% CI, 0.9 to 4.4; p 0.07) were the only variables predictive of sputum production at a level of significance of p 0.1. In particular, the pneumonia severity score was not associated with the probability of producing sputum (32% in pneumonia severity score classes 1 to 3 as compared to 38% in classes 4 and 5). In a multivariate analysis including the four variables with p 0.1, only age 75 years (OR, 0.4; 95% CI, 0.18 to 0.93; p 0.034) and prior ambulatory antimicrobial treatment (OR, 3.2; 95% CI, 1.2 to 8.4; p 0.019) remained as independent predictors of sputum production. Validity of Sputum Samples Of 42 samples, 35 samples (83%) were purulent according to macroscopic judgment. All 12 bacterial isolates cultured in moderate or high amounts in 10 patients were found in purulent sputum samples. Overall, macroscopic appearance was 100% (10 of 10 samples) sensitive and 22% (7 of 32 samples) specific for the prediction of growth in culture. Only 23 of 42 samples (55%) were considered microscopically valid as defined above. Macroscopic judgement predicted microscopic validity with a sensitivity of 91% (21 of 23 samples) and a specificity of 26% (5 of 19 samples). Gram Stains of Microscopically Valid Samples Gram stains were positive in 5 samples (22%) [with Gram-positive cocci in all cases] and negative in 1 sample (4%); the remaining 17 samples (74%) revealed a mixed flora. Sputum Cultures of Microbiologically Valid Samples Sputum samples were processed in the laboratory within the first 24 h in 11 cases (48%), within 48 h in another 10 cases (44%), and within 72 h and 96 h in 1 case each (4%). Overall, 16 pathogens (excluding 5 Candida spp) were cultured from 14 patients, including Streptococcus pneumoniae (n 4), Staphylococcus aureus (n 2), Haemophilus influenzae (n 4), Gram-negative enteric bacilli (GNEB; n 3), Pseudomonas aeruginosa (n 2), and Stenotrophomonas maltophilia (n 1). Twelve pathogens were present in moderate-to-high amounts. All four pathogens isolated in low amounts were either GNEB (n 2), P aeruginosa (n 1) or S maltophilia (n 1). However, of 23 samples, only 5 samples had a predominant organism on Gram stain; of these 5 samples, only 3 samples had concomitant growth in culture ( Clinical Investigations

4 samples with S pneumoniae and 1 sample with S aureus). The remaining two cases may have been false-negative results because of prior ambulatory antimicrobial treatment. Thus, applying strict criteria for the validity of a given isolate, overall 10 of 42 patients (24%) had a definite or probable diagnostic result in sputum samples (10 of 23 patients [44%] with valid sputum samples), with 12 pathogens isolated (Table 1). The number of valid specimen related to the diagnostic yield and the consequences for antimicrobial treatment decisions are summarized in Figure 1. Sputum investigation did not lead to reduction in the number of empiric antimicrobial agents in any case. Impact of Delays in Collecting and Processing of Sputum Samples Since empiric IV antimicrobial treatment was initiated as soon as possible after hospital admission, a delay in collecting a sputum sample always resulted in patients receiving therapy prior to sample collection (antimicrobial pretreatment). Thus, the number of isolates yielding GNEB and nonfermenters increased when pretreatment was done (4 of 9 isolates [44%] vs 1 of 14 isolates [7%]; OR, 10.4; 95% CI, 0.9 to 117.2; p 0.056). Three GNEB isolates were present in low quantities and were not diagnostic by definition. One significant isolate (Klebsiella oxytoca) was successfully treated with the empirical antimicrobial regimen (amoxicillin/clavulanic acid). A delay in processing was associated with an increase in the number of Candida spp isolates (4 of 12 isolates [33%] vs 1 of 11 isolates [9%]; OR, 5.0; 95% CI, 0.4 to 54.0; p 0.16). Isolates of GNEB and nonfermenters as well as Candida spp had both an 80% positive predictive value for delays in collecting and processing, respectively. Impact of COPD on Diagnostic Results In patients with a valid sputum sample, the presence of COPD was associated with a diagnostic yield twice as high as patients without COPD (7 of 12 Table 1 Overview of the Results of Microscopically Validated Sputum Samples in Relation to the Presence of COPD, Prior Ambulatory Antimicrobial Treatment, and Delays in Sampling and Processing* IDNR Macroscopic Validity Gram Stain Pathogens in Culture Bacterial Quantity COPD Prior ATB Delay in Sampling Delay in Processing 1 Purulent Mixed flora S pneumoniae No No No No H influenzae 2 Mucoid Mixed flora No Cef No No 3 Purulent Mixed flora P aeruginosa Yes No Yes No 4 Purulent Positive S pneumoniae Yes No No No 5 Purulent Mixed flora Yes Cef Yes Yes 6 Purulent Mixed flora No No No Yes 7 Purulent Positive S pneumoniae Yes No No Yes Candida spp 8 Purulent Mixed flora S pneumoniae No No Yes Yes K oxytoca 9 Purulent Mixed flora No No No Yes 10 Purulent Mixed flora Serratia spp Yes No No No 11 Purulent Mixed flora H influenzae Yes No No Yes 12 Purulent Positive No Pen Yes No 13 Purulent Mixed flora S maltophilia, No Tetra Yes No Candida spp 14 Purulent Mixed flora S aureus No No Yes No 15 Purulent Positive No Quino No No 16 Purulent Mixed flora H influenzae, Yes No No Yes Candida spp 17 Purulent Mixed flora H influenzae Yes No Yes Yes 18 Purulent Mixed flora Candida spp Yes Cef No Yes 19 Purulent Positive S aureus Yes Tetra No No 20 Mucoid Mixed flora Candida spp Yes No Yes Yes 21 Purulent Mixed flora Escherichia coli No No Yes No 22 Purulent Negative P aeruginosa Yes No No Yes 23 Purulent Mixed flora No No No Yes *IDNR patient identification number; ATB antimicrobial treatment; Cef oral cephalosporins; Pen oral penicillins; Tetra doxycycline; Quino oral quinolone. moderate-to-high growth on culture plates; low growth on culture plates. For definitions, see Methods section. CHEST / 121 / 5/ MAY,

5 Figure 1. Diagnostic yield of sputum cultures in 116 patients with CAP (36% of the population studied). patients [58%] with COPD vs 3 of 11 patients [27%] without COPD; OR, 3.7; 95% CI, 0.65 to 21.6; p 0.13), but this difference did not reach significance. Impact of Ambulatory Antimicrobial Treatment on Diagnostic Results Prior ambulatory antimicrobial treatment was associated with a fourfold reduction in diagnostic yield, although this difference did not achieve significance (1 of 7 patients [14%] vs 9 of 16 patients [56%]; OR, 0.13; 95% CI, 0.13 to 1.3; p 0.06). Impact of Diagnostic Results on Antimicrobial Treatment Decisions Only one patient with a positive result in a valid sample (S aureus) who did not respond to initial empiric antimicrobial treatment received a targeted treatment according to culture results that differed from the ERS guideline-recommended empiric treatment. This directed treatment was successful. Discussion The present study demonstrates the limited value of sputum as a diagnostic tool in the initial evaluation of patients with CAP admitted to a primary-care hospital. The limitations include failure to obtain a sputum sample from most patients, delay in collection and laboratory processing of samples, low diagnostic yield, and minimal impact on therapeutic decisions. Of the 42 sputum samples collected from this population of 116 patients, only 23 samples (55%) were valid when standard microscopic criteria were applied, thereby substantially reducing the number of evaluable patients. Using these criteria, a macroscopic purulent appearance had a high false-positive rate of predicting validity. The same was true for predictions of subsequent growth in culture based on macroscopic appearance. These observations confirm and extend previous data. 8 Thus, it is hardly possible to replace microscopic validation by the use of more readily available macroscopic criteria. Only a minority of patients (36%) were able to produce a sputum sample. Failures were due to nonproductive cough, weakness, and noncompliance. An age 75 years was the most important predictor of a failure to produce sputum. The positive association between prior ambulatory antimicrobial treatment and ability to produce a sample may simply reflect the fact that general practitioners believed that patients with productive cough were more likely to have bacterial pneumonia and need antibiotic therapy. Our findings show a generally lower frequency of collecting sputum samples than in previous studies, which reported failure in 20 to 70% of patients, with particularly low rates in the elderly. 23,24 Since the low rate of collecting a sample is unlikely to be increased by any intervention, sputum sampling is unable to be part of the initial microbial investigation in a considerable proportion of hospitalized patients with CAP. The delay in collection and laboratory processing of sputum samples was considerable, with 31% collected and 52% processed 24 h after hospital admission. These delays are mostly explained by weekends and nonworking days, and may represent a problem even in prospective studies. 25 Delays in collection resulted in antimicrobial pretreatment, thereby affecting the specificity of culture results, which demonstrated an increased recovery of GNEB and nonfermenters. Although we are not able to define exactly the impact of processing delays on the sensitivity of sputum cultures, it is known that common respiratory pathogens such as S pneumoniae and H influenzae are easily missed when samples are processed after 4 h. In addition, it was evident that delays in processing were associated with an increase in the isolation of Candida spp. Thus, the isolation of Candida spp in sputum samples of nonimmunosuppressed patients may be regarded as marker of overgrowth with colonizing organisms and not true pathogens. Gram stains had a low diagnostic yield, and a low 1490 Clinical Investigations

6 number of positive samples had a corresponding growth in culture. One explanation may be the lack of investigators who were familiar with the evaluation of Gram stains. In fact, the yield of Gram stains has proven to be highly dependent on a skilled investigator applying strict criteria. 26,27 In one study, 15% of the samples prepared by a house officer were technically inadequate, and the interpretations were often incorrect, with 50% of the pneumococcal readings being false-positive, and many of the H influenzae samples being false-negative. 27 However, if experienced laboratory technicians are not able to examine specimens, it is highly improbable that Gram stains can be accurately used in primarycare hospitals. In a study correlating Gram stain with the culture recovery of S pneumoniae from culture, it could be shown that applying liberal criteria such as any Gram-positive diplococcus resulted in a sensitivity of 83%, but with a specificity of only 38%. If the criterion for positive was a preponderance of Grampositive cocci, then the sensitivity dropped to 48% while specificity rose to 100%. 7 The updated American Thoracic Society guidelines advise that if a Gram stain is used to guide initial antimicrobial treatment, it should be with highly sensitive criteria, with the primary purpose being to visualize a microorganism that was not anticipated by the clinical scenario. 5 In our study, the yield of sputum was limited, even when liberal criteria were applied. It provided diagnostic results in only 10 of 116 patients (9%), 10 of 42 patients (24%) who produced sputum, and 10 of 23 patients (44%) with a microscopically valid sputum sample, respectively. The yield was somewhat higher in COPD patients, but since colonization with high bacterial loads may be present in up to 25%, it may be difficult to account for the effect of colonizing pathogens in the interpretation of sputum culture results. 28,29 Clearly, prior ambulatory antimicrobial treatment decreased the diagnostic yield, but in view of data 30,31 suggesting that any delay in treatment may be harmful in terms of outcome, it is not appropriate to discourage ambulatory treatment in order to increase diagnostic yield. The impact of sputum sample data on therapeutic decisions was negligible. Only one patient had a benefit from the identification of the underlying pathogen in sputum. This patient might have been diagnosed equally if he was reinvestigated after the failure of the initial antimicrobial treatment. Similar results have also been reported when evaluating the value of routine microbial investigation in different hospital settings In these studies, sputum smears and cultures added very little to the management and outcome of patients who received an appropriate initial antimicrobial regimen. In patients with treatment failures, mortality was not different, regardless of whether treatment was changed empirically or changed on the basis of diagnostic tests. We are unsure to what extent the results of the present study can be applied to other hospital settings. In fact, it has been repeatedly demonstrated that higher diagnostic yields can be achieved in different hospital settings and patient populations. 18,20 22,25 However, even in the most favorable report, originating from an experienced, university tertiary-care hospital, valid sputum samples could only be obtained in 39% of patients, with a predominant microorganism on Gram stain in 31% of patients. Moreover, the final difference in broad-spectrum vs pathogen-directed antimicrobial treatment, in the groups with and without diagnostic Gram stain, was only 14%. 36 Thus, the impact of diagnostic testing on therapeutic decisions also seems limited in settings interested in the study of pneumonia. However, data 37 highlighting an improved outcome for patients treated with a cephalosporin/macrolide combination or a quinolone, compared to a cephalosporin monotherapy regimen, raise serious doubts about the value of using focused antimicrobial treatment according to sputum findings. We believe that our results, reflecting implementation of a diagnostic strategy in a primary-care hospital not particularly interested in the field of respiratory infections, are representative of comparable hospitals in Germany. Moreover, our findings demonstrate that the yield and impact of sputum samples should be evaluated in each particular setting in order to establish a management approach for CAP that is designed according to local capabilities and facilities. As a result, we conclude that sputum collection cannot be recommended as part of a management algorithm in German patients with CAP treated in a primary-care hospital that does not have on-site microbiology facilities. References 1 American Thoracic Society. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148: British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults admitted to the hospital. Br J Hosp Med 1993; 49: Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000; 31: Mandell LA, Marrie TJ, Grossman RF, et al. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000; 31: American Thoracic Society. Guidelines for the management CHEST / 121 / 5/ MAY,

7 of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: European Study on Community-Acquired Pneumonia (ESO- CAP) Committee: guidelines for management of adult community-acquired lower respiratory tract infections. Eur Respir J 1998; 11: Deutsche Gesellschaft für Pneumologie: Empfehlungen zur Therapie der ambulant erworbenen Pneumonie. Pneumologie 1998; 52: Rein MF, Gwaltney JM Jr, O Brien WM, et al. Accuracy of Gram s stain in identifying pneumococci in sputum. JAMA 1978; 239: Lentino JR, Lucks DA. Nonvalue of sputum culture in the management of lower respiratory tract infections. J Clin Microbiol 1987; 25: MacDonald KS, Scriver SR, Low DE. Community-acquired pneumonia: the future of the microbiology laboratory; focused diagnosis or syndromic management? Semin Respir Infect 1994; 9: San Pedro GS, Campbell GD Jr. Limitations of diagnostic testing in the initial management of patients with communityacquired pneumonia. Semin Respir Infect 1997; 12: Gleckman R, DeVita J, Hibert D, et al. Sputum Gram stain assessment in community-acquired bacteremic pneumonia. J Clin Microbiol 1988; 26: Bartlett JG, Mundy MA. Community-acquired pneumonia. N Engl J Med 1995; 333: Skerrett SJ. Diagnostic testing to establish a microbial cause is helpful in the management of community-acquired pneumonia. Semin Respir Infect 1997; 12: Dorca J, Manresa F. Community-acquired pneumonia: initial management and empirical treatment. Eur Respir Mon 1997; 2: Ewig S, Seifert K, Kleinfeld T, et al. Management of patients with community-acquired pneumonia in a primary care hospital: a critical evaluation. Respir Med 2000; 94: Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: Ruiz M, Ewig S, Marcos MA, et al. Etiology of communityacquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999; 160: Marrie TJ, Durant H, Yates L. Community acquired pneumonia requiring hospitalisation: 5-year prospective study. Rev Infect Dis 1989; 11: Karalus NC, Cursons RT, Leng RA, et al. Communityacquired pneumonia: aetiology and prognostic index evaluation. Thorax 1991; 46: Blanquer J, Blanquer R, Borras R, et al. Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study. Thorax 1991; 46: Neill AM, Martin IR, Weir R, et al. Community-acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 51: Marrie TJ, Haldane EV, Faulkner R, et al. Community acquired pneumonia requiring hospitalization: is it different in the elderly? J Am Geriatr Soc 1985; 33: Riquelme R, Torres A, El-Ebiary M, et al. Communityacquired pneumonia in the elderly: a multivariate analysis of risk and prognosis. Am J Respir Crit Care Med 1996; 154: British Thoracic Society and the Public Health Laboratory Service. Community-acquired pneumonia in adults in British hospitals in : a survey of aetiology; mortality, prognostic factors and outcome. QJM 1987; 239: Fine MJ, Orloff JJ, Rihs JD, et al. Evaluation of housestaff physicians preparation and interpretation of sputum Gram stains for community-acquired pneumonia. J Gen Intern Med 1991; 6: Reed WW, Byrd GS, Gates RH Jr, et al. Sputum Gram s stain in community-acquired pneumococcal pneumonia: a metaanalysis. West J Med 1996; 165: Cabello H, Torres A, Celis R, et al. Distal airway bacterial colonisation in healthy subjects and chronic lung diseases: a bronchoscopic study. Eur Respir J 1997; 10: Monsó E, Ruiz J, Rosell A, et al. Bacterial infection in chronic obstructive pulmonary disease: a study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995; 152: Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997; 278: Ruiz M, Ewig S, Torres A, et al. Severe community-acquired pneumonia: risk factors and follow-up epidemiology. Am J Respir Crit Care Med 1999; 160: Woodhead MA, Arrowsmith J, Chamberlain-Webber R, et al. The value of routine microbial investigation in communityacquired pneumonia. Respir Med 1991; 85: Ewig S, Bauer T, Hasper E, et al. Value of routine microbial investigation in community acquired pneumonia treated in a tertiary care center. Respiration 1996; 63: Sanyal S, Smith PR, Saha AC, et al. Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia. Am J Respir Crit Care Med 1999; 160: Theerthakarai R, El-Halees W, Ismail M, et al. Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired pneumonia. Chest 2001; 119: Roson B, Carratala J, Verdaguer R, et al. Prospective study of the usefulness of sputum Gram stain in an approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis 2000; 31: Gleason PP, Meehan TP, Fine JM, et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999; 159: Clinical Investigations

Repeated Pneumonia Severity Index Measurement After Admission Increases its Predictive Value for Mortality in Severe Community-acquired Pneumonia

Repeated Pneumonia Severity Index Measurement After Admission Increases its Predictive Value for Mortality in Severe Community-acquired Pneumonia ORIGINAL ARTICLE Repeated Pneumonia Severity Index Measurement After Admission Increases its Predictive Value for Mortality in Severe Community-acquired Pneumonia Chiung-Zuei Chen, 1 Po-Sheng Fan, 2 Chien-Chung

More information

Making the Right Call With. Pneumonia. Community-acquired pneumonia (CAP) is a. Community-Acquired. What exactly is CAP?

Making the Right Call With. Pneumonia. Community-acquired pneumonia (CAP) is a. Community-Acquired. What exactly is CAP? Making the Right Call With Community-Acquired Pneumonia In this article: By Thomas J. Marrie, MD The case of Allyson Allyson, 32, presented to the emergency department with a 48-hour history of anorexia,

More information

Community-Acquired Pneumonia OBSOLETE 2

Community-Acquired Pneumonia OBSOLETE 2 Community-Acquired Pneumonia OBSOLETE 2 Clinical practice guidelines serve as an educational reference, and do not supersede the clinical judgment of the treating physician with respect to appropriate

More information

KAISER PERMANENTE OHIO COMMUNITY ACQUIRED PNEUMONIA

KAISER PERMANENTE OHIO COMMUNITY ACQUIRED PNEUMONIA KAISER PERMANENTE OHIO COMMUNITY ACQUIRED PNEUMONIA Methodology: Expert opinion Issue Date: 8-97 Champion: Pulmonary Medicine Most Recent Update: 6-08, 7-10, 7-12 Key Stakeholders: Pulmonary Medicine,

More information

WORKSHOP. The Multiple Facets of CAP. Community acquired pneumonia (CAP) continues. Jennifer s Situation

WORKSHOP. The Multiple Facets of CAP. Community acquired pneumonia (CAP) continues. Jennifer s Situation Practical Pointers pointers For for Your your Practice practice The Multiple Facets of CAP Dr. George Fox, MD, MSc, FRCPC, FCCP Community acquired pneumonia (CAP) continues to be a significant health burden

More information

Management of patients with community-acquired pneumonia in a primary care hospital: a critical evaluation

Management of patients with community-acquired pneumonia in a primary care hospital: a critical evaluation RESPIRATORY MEDICINE (2000) 94, 556±563 doi:10.1053/rmed.1999.0775, available online at http://www.idealibrary.com on Management of patients with community-acquired pneumonia in a primary care hospital:

More information

A Comparative Study of Community-Acquired Pneumonia Patients Admitted to the Ward and the ICU*

A Comparative Study of Community-Acquired Pneumonia Patients Admitted to the Ward and the ICU* CHEST Original Research A Comparative Study of Community-Acquired Pneumonia Patients Admitted to the Ward and the ICU* Marcos I. Restrepo, MD, MSc, FCCP; Eric M. Mortensen, MD, MSc; Jose A. Velez, MD;

More information

Pneumonia and influenza combined are the fifth leading

Pneumonia and influenza combined are the fifth leading Community-Acquired Pneumonia in Older Veterans: Does the Pneumonia Prognosis Index Help? Lona Mody, MD,* Rongjun Sun, PhD, and Suzanne Bradley, MD* OBJECTIVES: Mortality rates from pneumonia increase steadily

More information

Community-acquired pneumonia in adults

Community-acquired pneumonia in adults Prim Care Clin Office Pract 30 (2003) 155 171 Community-acquired pneumonia in adults Julio A. Ramirez, MD a,b, * a Department of Medicine, University of Louisville School of Medicine, 512 S. Hancock Street,

More information

S evere community acquired pneumonia (CAP) is an

S evere community acquired pneumonia (CAP) is an 421 RESPIRATORY INFECTION Validation of predictive rules and indices of severity for community acquired pneumonia S Ewig, A de Roux, T Bauer, E García, J Mensa, M Niederman, A Torres... See end of article

More information

S evere community acquired pneumonia (CAP) is an

S evere community acquired pneumonia (CAP) is an 421 RESPIRATORY INFECTION Validation of predictive rules and indices of severity for community acquired pneumonia S Ewig, A de Roux, T Bauer, E García, J Mensa, M Niederman, A Torres... See end of article

More information

PULMONARY EMERGENCIES

PULMONARY EMERGENCIES EMERGENCIES I. Pneumonia A. Bacterial Pneumonia (most common cause of a focal infiltrate) 1. Epidemiology a. Accounts for up to 10% of hospital admissions in the U.S. b. Most pneumonias are the result

More information

Chapter 22. Pulmonary Infections

Chapter 22. Pulmonary Infections Chapter 22 Pulmonary Infections Objectives State the incidence of pneumonia in the United States and its economic impact. Discuss the current classification scheme for pneumonia and be able to define hospital-acquired

More information

Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults

Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults International Journal of Infectious Diseases (2005) 9, 274 279 http://intl.elsevierhealth.com/journals/ijid Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract

More information

Chest radiography in patients suspected of pneumonia in primary care: diagnostic yield, and consequences for patient management

Chest radiography in patients suspected of pneumonia in primary care: diagnostic yield, and consequences for patient management Chest radiography in patients suspected of pneumonia in primary care: diagnostic yield, and consequences for patient management 4 Speets AM, Hoes AW, Van der Graaf Y, Kalmijn S, Sachs APE, Mali WPThM.

More information

Prospective Study of the Usefulness of Sputum Gram Stain in the Initial Approach to Community-Acquired Pneumonia Requiring Hospitalization

Prospective Study of the Usefulness of Sputum Gram Stain in the Initial Approach to Community-Acquired Pneumonia Requiring Hospitalization 869 Prospective Study of the Usefulness of Sputum Gram Stain in the Initial Approach to Community-Acquired Pneumonia Requiring Hospitalization Beatriz Rosón, Jordi Carratalà, Ricard Verdaguer, Jordi Dorca,

More information

Validation of sputum Gram stain for treatment of community-acquired pneumonia and healthcare-associated pneumonia: a prospective observational study

Validation of sputum Gram stain for treatment of community-acquired pneumonia and healthcare-associated pneumonia: a prospective observational study Fukuyama et al. BMC Infectious Diseases 2014, 14:534 RESEARCH ARTICLE Open Access Validation of sputum Gram stain for treatment of community-acquired pneumonia and healthcare-associated pneumonia: a prospective

More information

Community Acquired Pneumonia. Background & Rationale to North American Guidelines. Lionel Mandell MD FRCPC Brussels Belgium

Community Acquired Pneumonia. Background & Rationale to North American Guidelines. Lionel Mandell MD FRCPC Brussels Belgium Community Acquired Pneumonia Background & Rationale to North American Guidelines Lionel Mandell MD FRCPC Brussels Belgium Consider Impact of the disease Issues to reflect upon Impact of the Disease 3-4

More information

Epidemiology and Etiology of Community-Acquired Pneumonia 761 Lionel A. Mandell

Epidemiology and Etiology of Community-Acquired Pneumonia 761 Lionel A. Mandell LOWER RESPIRATORY TRACT INFECTIONS Preface Thomas M. File, Jr xiii Community-Acquired Pneumonia: Pathophysiology and Host Factors with Focus on Possible New Approaches to Management of Lower Respiratory

More information

COPD guidelines in relation to infections: a critical analysis

COPD guidelines in relation to infections: a critical analysis All course materials, including the original lecture, are available as webcasts/podcasts at www.ers-educationorg pages/default. aspx?id=1339&idbrowse=47399 COPD guidelines in relation to infections: a

More information

Delayed Administration of Antibiotics and Atypical Presentation in Community-Acquired Pneumonia*

Delayed Administration of Antibiotics and Atypical Presentation in Community-Acquired Pneumonia* CHEST Delayed Administration of Antibiotics and Atypical Presentation in Community-Acquired Pneumonia* Grant W. Waterer, MD, FCCP; Lori A. Kessler, PharmD; and Richard G. Wunderink, MD, FCCP Original Research

More information

Mædica - a Journal of Clinical Medicine

Mædica - a Journal of Clinical Medicine Mædica - a Journal of Clinical Medicine ORIGINAL PAPERS Mortality Risk and Etiologic Spectrum of Community-acquired Pneumonia in Hospitalized Adult Patients Cornelia TUDOSE, Assistant Professor of Pneumology;

More information

Predictors of Outcomes of Community Acquired Pneumonia in Egyptian Older Adults

Predictors of Outcomes of Community Acquired Pneumonia in Egyptian Older Adults Original Contribution/Clinical Investigation Predictors of Outcomes of Community Acquired Pneumonia in Egyptian Older Adults Hossameldin M. M. Abdelrahman Amal E. E. Elawam Ain Shams University, Faculty

More information

Acceptability of Sputum Specimens

Acceptability of Sputum Specimens JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 1982, p. 627-631 0095-1137/82/100627-05$02.00/0 Copyright C 1982, American Society for Microbiology Vol. 16, No. 4 Comparison of Six Different Criteria for Judging

More information

Charles Krasner, M.D. University of NV, Reno School of Medicine Sierra NV Veterans Affairs Medical Center

Charles Krasner, M.D. University of NV, Reno School of Medicine Sierra NV Veterans Affairs Medical Center Charles Krasner, M.D. University of NV, Reno School of Medicine Sierra NV Veterans Affairs Medical Center Kathy Peters is a 63 y.o. patient that presents to your urgent care office today with a history

More information

Community Acquired Pneumonia: Measures to Improve Management and Healthcare Quality

Community Acquired Pneumonia: Measures to Improve Management and Healthcare Quality Community Acquired Pneumonia: Measures to Improve Management and Healthcare Quality Gonzalo Bearman MD, MPH Assistant Professor of Internal Medicine Divisions of Quality Health Care & Infectious Diseases

More information

Early mortality in patients with communityacquired pneumonia: causes and risk factors

Early mortality in patients with communityacquired pneumonia: causes and risk factors Eur Respir J 2008; 32: 733 739 DOI: 10.1183/09031936.00128107 CopyrightßERS Journals Ltd 2008 Early mortality in patients with communityacquired : causes and risk factors C. Garcia-Vidal*, N. Fernández-Sabé*,

More information

K L Buising, K A Thursky, J F Black, L MacGregor, A C Street, M P Kennedy, G V Brown...

K L Buising, K A Thursky, J F Black, L MacGregor, A C Street, M P Kennedy, G V Brown... 419 RESPIRATORY INFECTION A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia K L Buising, K A

More information

11/19/2012. The spectrum of pulmonary diseases in HIV-infected persons is broad.

11/19/2012. The spectrum of pulmonary diseases in HIV-infected persons is broad. The spectrum of pulmonary diseases in HIV-infected persons is broad. HIV-associated Opportunistic infections Neoplasms Miscellaneous conditions Non HIV-associated Antiretroviral therapy (ART)-associated

More information

MDR AGENTS: RISK FACTORS AND THERAPEUTIC STRATEGIES

MDR AGENTS: RISK FACTORS AND THERAPEUTIC STRATEGIES MDR AGENTS: RISK FACTORS AND THERAPEUTIC STRATEGIES 1 Marin H. Kollef, MD Professor of Medicine Virginia E. and Sam J. Golman Chair in Respiratory Intensive Care Medicine Washington University School of

More information

Bronchiectasis Domiciliary treatment. Prof. Adam Hill Royal Infirmary and University of Edinburgh

Bronchiectasis Domiciliary treatment. Prof. Adam Hill Royal Infirmary and University of Edinburgh Bronchiectasis Domiciliary treatment Prof. Adam Hill Royal Infirmary and University of Edinburgh Plan of talk Background of bronchiectasis Who requires IV antibiotics Domiciliary treatment Results to date.

More information

Pneumonia Community-Acquired Healthcare-Associated

Pneumonia Community-Acquired Healthcare-Associated Pneumonia Community-Acquired Healthcare-Associated Edwin Yu Clin Infect Dis 2007;44(S2):27-72 Am J Respir Crit Care Med 2005; 171:388-416 IDSA / ATS Guidelines Microbiology Principles and Practice of Infectious

More information

Antimicrobial Stewardship in Community Acquired Pneumonia

Antimicrobial Stewardship in Community Acquired Pneumonia Antimicrobial Stewardship in Community Acquired Pneumonia Medicine Review Course 2018 Dr Lee Tau Hong Consultant Department of Infectious Diseases National Centre for Infectious Diseases Scope 1. Diagnosis

More information

Treatment of febrile neutropenia in patients with neoplasia

Treatment of febrile neutropenia in patients with neoplasia Treatment of febrile neutropenia in patients with neoplasia George Samonis MD, PhD Medical Oncologist Infectious Diseases Specialist Professor of Medicine The University of Crete, Heraklion,, Crete, Greece

More information

To develop guidelines for the use of appropriate antibiotics for adult patients with CAP and guidance on IV to PO conversion.

To develop guidelines for the use of appropriate antibiotics for adult patients with CAP and guidance on IV to PO conversion. Page 1 of 5 TITLE: COMMUNITY-ACQUIRED PNEUMONIA (CAP) EMPIRIC MANAGEMENT OF ADULT PATIENTS AND IV TO PO CONVERSION GUIDELINES: These guidelines serve to aid clinicians in the diagnostic work-up, assessment

More information

CAP, HCAP, HAP, VAP. 1. In 1898, William Osler described community-acquired pneumonia as:

CAP, HCAP, HAP, VAP. 1. In 1898, William Osler described community-acquired pneumonia as: 1. In 1898, William Osler described community-acquired pneumonia as: Brad Sharpe, M.D. Professor of Clinical Medicine Department of Medicine UCSF sharpeb@medicine.ucsf.edu I have no relevant financial

More information

Correlation of Sputum Gram Stain and Sputum Culture for Respiratory Tract Infections in a Tertiary Care Hospital, Ballari, India

Correlation of Sputum Gram Stain and Sputum Culture for Respiratory Tract Infections in a Tertiary Care Hospital, Ballari, India International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 6 (2017) pp. 3008-3012 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.606.357

More information

HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY

HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health

More information

Diagnostic Value of Sputum Gram s Stain and Sputum Culture in Lower Respiratory Tract Infections in a Tertiary Care Hospital

Diagnostic Value of Sputum Gram s Stain and Sputum Culture in Lower Respiratory Tract Infections in a Tertiary Care Hospital International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 7 (2017) pp. 4310-4314 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.607.448

More information

Clinical, radiological and bacteriological profile of patients with community acquired pneumonia (CAP)

Clinical, radiological and bacteriological profile of patients with community acquired pneumonia (CAP) Original Research Article Clinical, radiological and bacteriological profile of patients with community acquired pneumonia (CAP) R. S. Pushpa Kumari 1*, V. A. Vipula 2, Sonal Jain 3 1 Professor, Department

More information

Severe Community-acquired Pneumonia Risk Factors and Follow-up Epidemiology

Severe Community-acquired Pneumonia Risk Factors and Follow-up Epidemiology Severe Community-acquired Pneumonia Risk Factors and Follow-up Epidemiology MAURICIO RUIZ, SANTIAGO EWIG, ANTONI TORRES, FRANCISCO ARANCIBIA, FRANCESC MARCO, JOSEP MENSA, MIGUEL SANCHEZ, and JOSE ANTONIO

More information

Key words: bacteremia; community-acquired pneumonia; comorbid condition; diabetes mellitus; empyema; etiology; outcome; pleural effusion

Key words: bacteremia; community-acquired pneumonia; comorbid condition; diabetes mellitus; empyema; etiology; outcome; pleural effusion Etiology and Outcome of Community- Acquired Pneumonia in Patients With Diabetes Mellitus* Miquel Falguera, MD; Ricard Pifarre, MD; Antonio Martin, MD; Anas Sheikh, MD; and Anna Moreno, MD Study objectives:

More information

Brice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine

Brice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine Brice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine Discuss advances in predicting prognosis Understand dwhat we know (and don t know) about the Microbiology Recognize important

More information

CARE OF THE ADULT PNEUMONIA PATIENT

CARE OF THE ADULT PNEUMONIA PATIENT Care Guideline CARE OF THE ADULT PNEUMONIA PATIENT Target Audience: The target audience for this Care Guideline is all MultiCare providers and staff, including those associated with our clinically integrated

More information

I n the assessment and management of community acquired

I n the assessment and management of community acquired 377 RESPIRATORY INFECTION Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study W S Lim, M M van der Eerden, R Laing, W G Boersma,

More information

Work-up of Respiratory Specimens Now you can breathe easier

Work-up of Respiratory Specimens Now you can breathe easier 34 th Annual Meeting Southwestern Association of Clinical Microbiology Work-up of Respiratory Specimens Now you can breathe easier Yvette S. McCarter, PhD, D(ABMM) Director, Clinical Microbiology Laboratory

More information

Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT

Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT Target Audience: All MHS employed providers within Primary Care, Urgent Care, and In-Hospital Care. The secondary audience

More information

CHEST VOLUME 117 / NUMBER 4 / APRIL, 2000 Supplement

CHEST VOLUME 117 / NUMBER 4 / APRIL, 2000 Supplement CHEST VOLUME 117 / NUMBER 4 / APRIL, 2000 Supplement Evidence-Based Assessment of Diagnostic Tests for Ventilator- Associated Pneumonia* Executive Summary Ronald F. Grossman, MD, FCCP; and Alan Fein, MD,

More information

Severity assessment in community-acquired pneumonia. S. Ewig, H. SchaÈfer, A. Torres.

Severity assessment in community-acquired pneumonia. S. Ewig, H. SchaÈfer, A. Torres. Eur Respir J 2000; 16: 1193±1201 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 2000 European Respiratory Journal ISSN 0903-1936 SERIES "RECENT DEVELOPMENTS IN PULMONARY INFECTIONS" Edited

More information

Hospital-acquired Pneumonia

Hospital-acquired Pneumonia Hospital-acquired Pneumonia Hospital-acquired pneumonia (HAP) Pneumonia that occurs at least 2 days after hospital admission. The second most common and the leading cause of death due to hospital-acquired

More information

Community Acquired & Nosocomial Pneumonias

Community Acquired & Nosocomial Pneumonias Community Acquired & Nosocomial Pneumonias IDSA/ATS 2007 & 2016 Guidelines José Luis González, MD Clinical Assistant Professor of Medicine Outline Intro - Definitions & Diagnosing CAP treatment VAP & HAP

More information

THE PHARMA INNOVATION - JOURNAL Acute exacerbation of chronic obstructive pulmonary disease, caused by viruses: the need of combined antiinfective

THE PHARMA INNOVATION - JOURNAL Acute exacerbation of chronic obstructive pulmonary disease, caused by viruses: the need of combined antiinfective Received: 19-11-2013 Accepted: 28-12-2013 ISSN: 2277-7695 CODEN Code: PIHNBQ ZDB-Number: 2663038-2 IC Journal No: 7725 Vol. 2 No. 11. 2014 Online Available at www.thepharmajournal.com THE PHARMA INNOVATION

More information

A Study of Prognosis and Outcome of Community Acquired Pneumonia in a Tertiary Care Centre

A Study of Prognosis and Outcome of Community Acquired Pneumonia in a Tertiary Care Centre ISSN: 2319-7706 Volume 4 Number 8 (2015) pp. 763-769 http://www.ijcmas.com Original Research Article A Study of Prognosis and Outcome of Community Acquired Pneumonia in a Tertiary Care Centre Bhadra Reddy

More information

Healthcare-associated infections acquired in intensive care units

Healthcare-associated infections acquired in intensive care units SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Healthcare-associated infections acquired in intensive care units Key facts In 2015, 11 788 (8.3%) of patients staying in an intensive care unit

More information

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy Recommended Empirical Antibiotic Regimens for MICU Patients Notes: The antibiotic regimens shown are general guidelines and should not replace clinical judgment. Always assess for antibiotic allergies.

More information

LOWER RESPIRATORY tract infections

LOWER RESPIRATORY tract infections ORIGINAL INVESTIGATION Severity Assessment of Lower Respiratory Tract Infection in Elderly Patients in Primary Care Yrjö Seppä, MD; Aini Bloigu, BSc; Pekka O. Honkanen, MD, PhD; Liisa Miettinen, MD; Hannu

More information

How To Assess Severity and Prognosis

How To Assess Severity and Prognosis How To Assess Severity and Prognosis Gregory Tino, M.D. Chief, Department of Medicine Penn Presbyterian Medical Center Associate Professor of Medicine Perelman School of Medicine at the University of Pennsylvania

More information

ORIGINAL ARTICLE /j x

ORIGINAL ARTICLE /j x ORIGINAL ARTICLE 10.1111/j.1469-0691.2007.01915.x Factors impacting on length of stay and mortality of community-acquired pneumonia J. Garau 1, F. Baquero 2,E.Pérez-Trallero 3, J.-L. Pérez 4, A. M. Martín-Sánchez

More information

ETIOLOGIES AND TREATMENT OUTCOMES IN PATIENTS HOSPITALIZED WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP) AT SRINAGARIND HOSPITAL, KHON KAEN, THAILAND

ETIOLOGIES AND TREATMENT OUTCOMES IN PATIENTS HOSPITALIZED WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP) AT SRINAGARIND HOSPITAL, KHON KAEN, THAILAND SOUTHEAST ASIAN J TROP MED PUBLIC HEALTH ETIOLOGIES AND TREATMENT OUTCOMES IN PATIENTS HOSPITALIZED WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP) AT SRINAGARIND HOSPITAL, KHON KAEN, THAILAND Wipa Reechaipichitkul

More information

Etiology and clinical profile of inpatients with Community acquired pneumonia in Manipal Teaching hospital, Pokhara, Nepal

Etiology and clinical profile of inpatients with Community acquired pneumonia in Manipal Teaching hospital, Pokhara, Nepal Original Article Etiology and clinical profile of inpatients with Community acquired pneumonia in Manipal Teaching hospital, Pokhara, Nepal Shrestha R, 1* Paudel N, 1 Barakoti B, 1 Dhungana D, 1 Sharma

More information

Duration of antibiotic treatment and symptom recovery in community-acquired pneumonia El Moussaoui, R.

Duration of antibiotic treatment and symptom recovery in community-acquired pneumonia El Moussaoui, R. UvA-DARE (Digital Academic Repository) Duration of antibiotic treatment and symptom recovery in community-acquired pneumonia El Moussaoui, R. Link to publication Citation for published version (APA): El

More information

Severity prediction rules in community acquired pneumonia: a validation study

Severity prediction rules in community acquired pneumonia: a validation study Thorax 2000;55:219223 219 Severity prediction rules in community acquired pneumonia: a validation study W S Lim, S Lewis, J T Macfarlane Respiratory Medicine, City Hospital, Nottingham NG5 1PB, UK W S

More information

The McMaster at night Pediatric Curriculum

The McMaster at night Pediatric Curriculum The McMaster at night Pediatric Curriculum Community Acquired Pneumonia Based on CPS Practice Point Pneumonia in healthy Canadian children and youth and the British Thoracic Society Guidelines on CAP Objectives

More information

The Importance of Appropriate Treatment of Chronic Bronchitis

The Importance of Appropriate Treatment of Chronic Bronchitis ...CLINICIAN INTERVIEW... The Importance of Appropriate Treatment of Chronic Bronchitis An interview with Antonio Anzueto, MD, Associate Professor of Medicine, University of Texas Health Science Center,

More information

Blood cultures in ED. Dr Sebastian Chang MBBS FACEM

Blood cultures in ED. Dr Sebastian Chang MBBS FACEM Blood cultures in ED Dr Sebastian Chang MBBS FACEM Why do we care about blood cultures? blood cultures are the most direct method for detecting bacteraemia in patients a positive blood culture: 1. can

More information

A Cross-Sectional Study of Isolates from Sputum Samples from Bacterial Pneumonia Patients in Trinidad

A Cross-Sectional Study of Isolates from Sputum Samples from Bacterial Pneumonia Patients in Trinidad BJID 2005; 9 (June) 231 A Cross-Sectional Study of Isolates from Sputum Samples from Bacterial Pneumonia Patients in Trinidad Nabeetha A. Nagalingam 1, Abiodun A. Adesiyun 2, School of Medicine 1 and School

More information

Community Acquired Pneumonia

Community Acquired Pneumonia April 2014 References: 1. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL Mace SE, McCracken Jr. GH, Moor MR, St. Peter SD, Stockwell JA, and Swanson JT. The Management of

More information

Clinical failure, community-acquired pneumonia, management, outcome, prognosis, risk-factors

Clinical failure, community-acquired pneumonia, management, outcome, prognosis, risk-factors ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01535.x Prognostic factors for early clinical failure in patients with severe community-acquired pneumonia M. Hoogewerf 1, J. J. Oosterheert 1, E. Hak 2, I. M.

More information

ORIGINAL INVESTIGATION. Health Care Associated Pneumonia Requiring Hospital Admission. Epidemiology, Antibiotic Therapy, and Clinical Outcomes

ORIGINAL INVESTIGATION. Health Care Associated Pneumonia Requiring Hospital Admission. Epidemiology, Antibiotic Therapy, and Clinical Outcomes ORIGINAL INVESTIGATION Health Care Associated Pneumonia Requiring Hospital Admission Epidemiology, Antibiotic Therapy, and Clinical Outcomes Jordi Carratalà, MD, PhD; Analía Mykietiuk, MD; Núria Fernández-Sabé,

More information

Study of Bacteriological and Clinical Profile of Community Acquired Pneumonia in Type 2 Diabetes Patients in Tertiary Care Hospital, Warangal

Study of Bacteriological and Clinical Profile of Community Acquired Pneumonia in Type 2 Diabetes Patients in Tertiary Care Hospital, Warangal Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2018/92 Study of Bacteriological and Clinical Profile of Community Acquired Pneumonia in Type 2 Diabetes Patients in Poralla

More information

Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association

Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association Els Vandecasteele, Jan De Waele, Dominique Vandijck, Stijn Blot, Dirk

More information

an inflammation of the bronchial tubes

an inflammation of the bronchial tubes BRONCHITIS DEFINITION Bronchitis is an inflammation of the bronchial tubes (or bronchi), which are the air passages that extend from the trachea into the small airways and alveoli. Triggers may be infectious

More information

Polmoniti: Steroidi sì, no, quando. Alfredo Chetta Clinica Pneumologica Università degli Studi di Parma

Polmoniti: Steroidi sì, no, quando. Alfredo Chetta Clinica Pneumologica Università degli Studi di Parma Polmoniti: Steroidi sì, no, quando Alfredo Chetta Clinica Pneumologica Università degli Studi di Parma Number of patients Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive

More information

Pneumonia Severity Scores:

Pneumonia Severity Scores: Pneumonia Severity Scores: Are they Accurate Predictors of Mortality? JILL McEWEN, MD FRCPC Clinical Professor Department of Emergency Medicine University of British Columbia Vancouver, BC Canada President,

More information

HEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION

HEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION HEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health Care Medical

More information

Diagnosis of Ventilator- Associated Pneumonia: Where are we now?

Diagnosis of Ventilator- Associated Pneumonia: Where are we now? Diagnosis of Ventilator- Associated Pneumonia: Where are we now? Gary French Guy s & St. Thomas Hospital & King s College, London BSAC Guideline 2008 Masterton R, Galloway A, French G, Street M, Armstrong

More information

Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults

Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults Eur Respir J 2003; 21: 209 214 DOI: 10.1183/09031936.03.00058802 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2003 European Respiratory Journal ISSN 0903-1936 Rapid urinary antigen test

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory

More information

MAJOR ARTICLE. Beatriz Rosón, 1 Jordi Carratalà, 1 Jordi Dorca, 2 Aurora Casanova, 3 Frederic Manresa, 2 and Francesc Gudiol 1

MAJOR ARTICLE. Beatriz Rosón, 1 Jordi Carratalà, 1 Jordi Dorca, 2 Aurora Casanova, 3 Frederic Manresa, 2 and Francesc Gudiol 1 MAJOR ARTICLE Etiology, Reasons for Hospitalization, Risk Classes, and Outcomes of Community-Acquired Pneumonia in Patients Hospitalized on the Basis of Conventional Admission Criteria Beatriz Rosón, 1

More information

Lecture Notes. Chapter 16: Bacterial Pneumonia

Lecture Notes. Chapter 16: Bacterial Pneumonia Lecture Notes Chapter 16: Bacterial Pneumonia Objectives Explain the epidemiology Identify the common causes Explain the pathological changes in the lung Identify clinical features Explain the treatment

More information

Dr Conroy Wong. Professor Richard Beasley. Dr Sarah Mooney. Professor Innes Asher

Dr Conroy Wong. Professor Richard Beasley. Dr Sarah Mooney. Professor Innes Asher Professor Richard Beasley University of Otago Director Medical Research Institute of New Zealand Wellington Dr Sarah Mooney Physiotherapy Advanced Clinician Counties Manukau Health NZ Respiratory and Sleep

More information

Community Acquired Pneumonia. Abdullah Alharbi, MD, FCCP

Community Acquired Pneumonia. Abdullah Alharbi, MD, FCCP Community Acquired Pneumonia Abdullah Alharbi, MD, FCCP A 68 y/ male presented to the ED with SOB and productive coughing for 2 days. Reports poor oral intake since onset due to nausea and intermittent

More information

Markers of treatment failure in hospitalised community acquired pneumonia

Markers of treatment failure in hospitalised community acquired pneumonia 1 Servicio de Neumología, Hospital Universitario La Fe, Valencia, Spain; 2 CIBER de Enfermedades Respiratorias (CIBERES); 3 PPG Pneumologia- UFRGS, Brasil; 4 Servei de Malalties Infeccioses, Hospital Clínic,

More information

High-Dose Levofloxacin for the Treatment of Community-Acquired Pneumonia

High-Dose Levofloxacin for the Treatment of Community-Acquired Pneumonia High-Dose Levofloxacin for the Treatment of Community-Acquired Pneumonia Review Andrew F. Shorr, MD, MPH, FCCP Department of Medicine Pulmonary and Critical Care Medicine, Washington Hospital Center, Washington,

More information

JMSCR Vol 04 Issue 12 Page December 2016

JMSCR Vol 04 Issue 12 Page December 2016 www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v4i12.124 COPD: Microbial Pattern in Acute Exacerbation

More information

Management of Acute Exacerbations

Management of Acute Exacerbations 15 Management of Acute Exacerbations Cenk Kirakli Izmir Dr. Suat Seren Chest Diseases and Surgery Training Hospital Turkey 1. Introduction American Thoracic Society (ATS) and European Respiratory Society

More information

Airway bacterial colonization in patients with non-small cell lung cancer and the alterations during the perioperative period

Airway bacterial colonization in patients with non-small cell lung cancer and the alterations during the perioperative period Original Article Airway bacterial colonization in patients with non-small cell lung cancer and the alterations during the perioperative period Jiandong Mei 1, Lunxu Liu 1, Menglin Tang 2, Ninghui Xu 3,

More information

To Study The Cinico-Radiological Features And Associated Co-Morbid Conditions

To Study The Cinico-Radiological Features And Associated Co-Morbid Conditions IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 7 Ver. 16 (July. 2018), PP 58-62 www.iosrjournals.org To study the clinico-radiological features

More information

COPD exacerbation. Dr. med. Frank Rassouli

COPD exacerbation. Dr. med. Frank Rassouli Definition according to GOLD report: - «An acute event - characterized by a worsening of the patients respiratory symptoms - that is beyond normal day-to-day variations - and leads to a change in medication»

More information

Non-Resolving Pneumonia study in a Tertiary Care Hospital

Non-Resolving Pneumonia study in a Tertiary Care Hospital Original article: Non-Resolving Pneumonia study in a Tertiary Care Hospital 1Dr.Sabale B. B.Rao, 2 Dr.Ravishankar K, 3 DR. Dhananjay B. Sabale 1Consultant Physician, Sainath Hospital, Shirdi-423109, Maharashtra,

More information

Guess or get it right?

Guess or get it right? Guess or get it right? Antimicrobial prescribing in the 21 st century Robert Masterton Traditional Treatment Paradigm Conservative start with workhorse antibiotics Reserve more potent drugs for non-responders

More information

Investigation and Management of Community-Acquired Pneumonia (CAP) Frequently Asked Questions

Investigation and Management of Community-Acquired Pneumonia (CAP) Frequently Asked Questions Investigation and Management of Community-Acquired Pneumonia (CAP) Frequently Asked Questions 1. Why was this algorithm developed? Emergency department physicians were seeking guidance about best antimicrobial

More information

ANWICU knowledge

ANWICU knowledge ANWICU knowledge www.anwicu.org.uk This presenta=on is provided by ANWICU We are a collabora=ve associa=on of ICUs in the North West of England. Permission to provide this presenta=on has been granted

More information

Clinical and Bacteriological Profile of Hospitalised Community Acquired Pneumonia (CAP)

Clinical and Bacteriological Profile of Hospitalised Community Acquired Pneumonia (CAP) Clinical and Bacteriological Profile of Hospitalised Community Acquired (CAP) Dr. Jayant B. Chauhan 1, Dr. Ghanshyam B. Borisagar 2, Dr. (Mrs.) K. V. Shah 3 Abstract Community acquired pneumonia[cap] occurring

More information

Clinical Characteristics of Nursing and Healthcare-Associated Pneumonia: A Japanese Variant of Healthcare-Associated Pneumonia

Clinical Characteristics of Nursing and Healthcare-Associated Pneumonia: A Japanese Variant of Healthcare-Associated Pneumonia ORIGINAL ARTICLE Clinical Characteristics of Nursing and Healthcare-Associated Pneumonia: A Japanese Variant of Healthcare-Associated Pneumonia Tadashi Ishida, Hiromasa Tachibana, Akihiro Ito, Hiroshige

More information

Poor Predictive Ability of Urinalysis and Microscopic Examination to Detect Urinary Tract Infection

Poor Predictive Ability of Urinalysis and Microscopic Examination to Detect Urinary Tract Infection Microbiology and Infectious Disease / POOR PREDICTIVE ABILITY OF URINALYSIS Poor Predictive Ability of Urinalysis and Microscopic Examination to Detect Urinary Tract Infection Joy D. Van Nostrand, MS,

More information

HIV AND LUNG HEALTH. Stephen Aston Infectious Diseases SpR Royal Liverpool University Hospital

HIV AND LUNG HEALTH. Stephen Aston Infectious Diseases SpR Royal Liverpool University Hospital HIV AND LUNG HEALTH Stephen Aston Infectious Diseases SpR Royal Liverpool University Hospital Introduction HIV infection exerts multiple effects on pulmonary immune responses: Generalised state of immune

More information

COPD Treatable. Preventable.

COPD Treatable. Preventable. My COPD Action Plan Patient s Copy (Patient s Name) Date Canadian Respiratory COPD Treatable. Preventable. This is to tell me how I will take care of myself when I have a COPD flare-up. My goals are My

More information

Microbial aetiology of community-acquired pneumonia and its relation to severity

Microbial aetiology of community-acquired pneumonia and its relation to severity < Additional data are published online only. To view these files please visit the journal online (http://thorax.bmj.com). 1 Servei de Pneumologia, Institut del Tòrax, Hospital Clinic, IDIBAPS, Universitat

More information

Clinical characteristics of health care-associated pneumonia in a Korean teaching hospital

Clinical characteristics of health care-associated pneumonia in a Korean teaching hospital Respiratory Medicine (2010) 104, 1729e1735 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed Clinical characteristics of health care-associated pneumonia in a Korean teaching

More information